Design

"Designing medical innovations is not the exclusive reach of geniuses; it is rather the methodical discipline of outlining design criteria to craft products that satisfy them"

EMED design team...

 
EMED offers a comprehensive approach focusing on all aspects of the design of a new medical device.

ESTABLISHING DESIGN CRITERIA. The development process starts by establishing design criteria. Our team of knowledgeable professionals actively works with innovators, opinion leaders and other manufacturers to identify and respond to special market needs.

PARAMOUNT OBJECTIVE. Our paramount design criteria are the therapeutic efficacy and the safety and comfort of both clinicians and patients. We are proud to have pioneered several innovative product developments resulting in important clinical contributions.

MULTIDISCIPLINARY APPROACH. After the design criteria are outlined, a preliminary design is develop by a multidisciplinary team of engineers including: Mechanical, Electrical, Materials and Design specialties.


If you are a clinician, an inventor or a patient and have a novel or innovative product idea, contact us at:

idea@emedicaldevices.com

A design engineer will be in touch with you to discuss how EMED can assist you.

 

 

ENGINEERING. EMED offers a multidisciplinary design team that includes: Mechanical, Electrical, Materials and Design engineering. We utilize a consultative approach to interact with clinicians.

BUILDING BLOCKS. EMED has developed hundreds of sub-assemblies that facilitate the design and expedite the development process while ensuring regulatory compliance of a new medical device. Categories include: filters, IV components, needles, tubing and connectors.

RAW MATERIAL ANALYSIS. We start at analyzing the most basic level of raw materials used in the manufacture of a medical device. Categories include adhesives, coatings, compounds, filtration materials, plastics/elastomers, tubing, and other materials.


MATERIALS

• EMED carefully considers the optimization of its materials relative to biocompatibility and clinical performance.
• EMED standardized the use of non-DEHP materials for its infusion delivery product lines in 1995. Later, in 2006 EMED launched a new line of sub-cutaneous infusion devices with a patented PE liner that minimizes chemical interaction between the pharmaceutical product and the infusion delivery device. This decision exemplifies our commitment to offering products that incorporate features above regulatory requirements.